51029-21-1Relevant articles and documents
Targeting gliomas with triazene-based hybrids: Structure-activity relationship, mechanistic study and stability
Braga, Cláudia,Vaz, Ana R.,Oliveira, M. Concei??o,Matilde Marques,Moreira, Rui,Brites, Dora,Perry, Maria J.
, p. 16 - 25 (2019/04/04)
Herein we report novel hybrid compounds based on valproic acid and DNA-alkylating triazene moieties, 1, with therapeutic potential for glioblastoma multiforme chemotherapy. We identified hybrid compounds 1d and 1e to be remarkably more potent against glioma and more efficient in decreasing invasive cell properties than temozolomide and endowed with chemical and plasma stability. In contrast to temozolomide, which undergoes hydrolysis to release an alkylating metabolite, the valproate hybrids showed a low potential to alkylate DNA. Key physicochemical properties align for optimal CNS penetration, highlighting the potential of these effective triazene based-hybrids for enhanced anticancer chemotherapy.
Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines
Monteiro, Ana Sofia,Almeida, Joana,Cabral, Guadalupe,Severino, Paulo,Videira, Paula A.,Sousa, Ana,Nunes, Rafael,Pereira, Jo?o D.,Francisco, Ana Paula,Perry, M. Jesus,Mendes, Eduarda
, p. 1 - 9 (2013/11/06)
In this research work we report the synthesis of a new series of triazene prodrugs designed for Melanocyte-Directed Enzyme Prodrug Therapy (MDEPT). These compounds are derived from the N-acyltyrosine amino acid - a good enzyme substrate for the tyrosinase enzyme, which is significantly overexpressed in melanoma cells. We analysed their chemical stability and plasma enzymatic hydrolysis, and we also evaluated the release of the antitumoral drug in the presence of the tyrosinase. Subsequently, we performed the evaluation of the prodrug cytotoxicity in melanoma cell lines with different levels of tyrosinase activity. Prodrug 5c showed the highest cytotoxicity against melanoma cell lines, and this effect correlated well with the tyrosinase activity suggesting that prodrug cytotoxicity is tyrosinase-dependent.
Triazene Drug Metabolites. Part 9. Base Catalysed Deacylation of 3-Acyl-3-alkyl-1-aryltriazenes in Ethanol.
Iley, Jim,Ruecroft, Graham,Carvalho, Emilia,Rosa, Eduarda
, p. 1264 - 1273 (2007/10/02)
3-Acyl-3-alkyl-1-aryltriazenes undergo a base-catalysed deacylation reaction to liberate the corresponding cytotoxic 3-alkyl-1-aryltriazene.Reaction are first-order in both and .Second-order rate constants, k2, depend on the structure of both the substrate and the base.The values of k2 for the deformylation of 1-aryl-3-formyl-3-methyltriazenes by piperidine follow the Hammett relationship giving ρ +2.9; a similar correlation, ρ +1.6, is observed for the morpholine catalysed deacylation of 1-aryl-3-methyl-3-trifluoroacetyltriazenes.For 1-(4-cyanophenyl)-3-methyl-3-trifluoroacetyltriazene, a correlation between the aqueous pKa of the base and k2 is obtained, giving a Broensted β value of 0.36.The solvent deuterium isotope effect, k2EtOH/k2EtOD, for the piperidine-catalysed deacylation of 1-(3-pyridyl)-3-formyl-3-methyltriazene is 2.2, and 2,2,6,6-tetramethylpiperidine is some 2.4 times more effective than piperidine at catalysing the deformylation of this compound.Rate constants for the deacylation of 3-alkyltriazenes diminish in the order Me > Pr > Et.Rate constants also vary with the nature of the acyl group: thus CF3CO > HCO > MeCO > C8H17CO.The data are interpreted in terms of a mechanism that involves a rate-determining, general-base-catalysed attack of a solvent ethanol molecule at the carbonyl carbon atom of the group, followed by rapid collapse of the tetrahedral intermediate to form the monoalkyltriazene.
